Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The cat had liver cancer and a related hair loss condition, with a likely cause being bile duct cancer.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

Even a small melanoma can be deadly if not removed, regardless of the patient's age.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New compounds may help treat prostate cancer by reducing cell growth.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

CEC levels may be a useful marker for predicting prostate cancer progression.